NL-OMON43111已完成不适用
An open-label, randomized crossover pilot study to evaluate the pharmacokinetics, bioavailability, and bioequivalence following administration of Oxybate formulations in healthy subjects. - KEY-507 PK, BA and BE Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female volunteers
- •18 - 45 years of age, inclusive
- •BMI 20 - 30 kg/m2, inclusive
- •minimum bodyweight 60 kg
- •non smoking
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
An open-label, randomized, crossover, pilot study to assess the efficacy of Nutren diabetes, in maintenance of blood glucose level in patients with type 2 diabetes (T2DM)CTRI/2011/10/002089estle40
已完成
不适用
An Open-Label, Randomized, Crossover Pilot Study to Evaluate the Pharmacokinetics and Relative Bioavailability of JZP-324 Formulations vs. Xyrem in Healthy SubjectsNL-OMON48951Jazz Pharmaceuticals, inc.60
已完成
不适用
An open label, cross over pilot study to evaluate the effect of a single dose of TW001 on the oxidative stress and pharmacokinetics with and without food in patients with amyotrophic lateral sclerosisNL-OMON42324Treeway B.V.8
进行中（未招募）
不适用
Open, randomized, two-way crossover, pilot study to assess the effect of Salbutamol in comparison with Ipratropium bromide on central and peripheral airway dimensions in COPD patientsChronic Obstructive Pulmonary DiseaseEUCTR2008-000609-12-BEniversity Hospital Antwerp; Department Respiratory Medicine
已完成
不适用
A randomized, open-label, crossover study to evaluate ICS/LABA treatment versus LAMA/LABA treatment in COPD with eosinophilic inflammatioCOPDJPRN-UMIN000024905Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital25